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Abstract
BmpA is an immunodominant protein of Borrelia burgdorferi as well as an arthritogenic factor.
Rabbit anti-recombinant BmpA (rBmpA) antibodies were raised, characterized by assaying their
cross reactivity with rBmpB, rBmpC and rBmpD, then rendered monospecific by absorption with
rBmpB. This monospecific reagent reacted only with rBmpA in dot immunobinding and detected
a single 39-kDa, pI 5.0, spot on two-dimensional immunoblots. It was used to assess BmpA
cellular location. BmpA was present in both detergent-soluble and -insoluble fractions of Triton
X-114 phase-partitioned borrelial cells, suggesting it was a membrane lipoprotein. Immunoblots of
proteinase K-treated intact and Triton X-100 permeabilized cells showed digestion of BmpA in
intact cells, consistent with surface exposure. This exposure was confirmed by dual-label
immunofluorescence microscopy of intact and permeabilized borrelial cells. Conservation and
surface localization of BmpA in all B. burgdorferi sensu lato genospecies could point to its
playing a key role in this organism’s biology and pathobiology.
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Introduction
The Borrelia burgdorferi B31 genome contains many genes coding for putative lipoproteins
(4.9% of the chromosomal genes, 14.5% of the plasmid genes) (Fraser, Casjens S, Huang
WM et al., 1997; Casjens, Palmer N, van Vugt R et al., 2000). Lipoproteins are usually
considered structural components of the cell, but surface-exposed lipoproteins of B.
burgdorferi can also be involved in interactions with hosts (Fraser, Casjens S, Huang WM et
al., 1997; Casjens, Palmer N, van Vugt R et al., 2000; Liang, Nelson FK, & Fikrig E, 2002;
Xu, McShan K, & Liang FT, 2008). Sequential expression of these borrelial lipoproteins in
infected ticks and mammals by tightly regulated global regulatory mechanisms also
underlines their relevance for the successful life cycle of this pathogen (Revel, Talaat AM,
& Norgard MV, 2002; He, Oman T, Xu H, Blevins J, Norgard MV, & Yang XF, 2008).
Lipoproteins such as OspA and OspC are involved in the interaction of borrelia with
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intestinal and salivary epithelia of ticks, respectively (Pal, de Silva AM, Montgomery RR,
Fish D, Anguita J, Anderson JF, Lobet Y, & Fikrig E, 2000; Pal, Yang X, Chen M,
Bockenstedt LK, Anderson JF, Flavell RA, Norgard MV, & Fikrig E, 2004; Strother, Hodzic
E, Barthold SW, & de Silva AM, 2007; Radolf & Caimano MJ, 2008). VlsE plays a role in
evading antibacterial effects of antibodies (Zhang, Hardham JM, Barbour AG, & Norris SJ,
1997; Zhang & Norris SJ, 1998; Xu, McShan K, & Liang FT, 2008). OspE and ErpA are
involved in the ability of B. burgdorferi to evade complement by interacting with human
factor H and plasminogen (Hellwage, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P,
Seppala IJ, & Meri S, 2001; Stevenson, El Hage N, Hines MA, Miller JC, & Babb K, 2002).
Many borrelial lipoproteins mediate the organism’s adhesion to integrins and host
extracellular matrix molecules (Cabello, Godfrey HP, & Newman SA, 2007). P66, BBB07
and DbpA/DbpB bind to αIIβ3/αvβ3, α3β1 and decorin (Guo, Norris SJ, Rosenberg LC, &
Höök M, 1995; Guo, Brown EL, Dorward DW, Rosenberg LC, & Höök M, 1998; Coburn &
Cugini C, 2003; Behera, Durand E, Cugini C, Antonara S, Bourassa L, Hildebrand E, Hu
LT, & Coburn J, 2008), Bgp, DbpA and DbpB bind to glycosaminoglycans, heparin and
dermatan sulfate (Parveen & Leong JM, 2000; Parveen, Caimano M, Radolf JD, & Leong
JM, 2003), and BBK32 and RevA bind to fibronectin (Seshu, Esteve-Gassent MD,
Labandeira-Rey M, Kim JH, Trzeciakowski JP, Höök M, & Skare JT, 2006; Brissette,
Bykowski T, Cooley AE, Bowman A, & Stevenson B, 2009).
Another lipoprotein, BmpA, is highly immunogenic in human beings and animals and is one
of the antigens used in serodiagnostic tests for Lyme disease (Aguero-Rosenfeld, Wang G,
Schwartz I, & Wormser GP, 2005; Bryksin, Godfrey HP, Carbonaro CA, Wormser GP,
Aguero-Rosenfeld ME, & Cabello FC, 2005). It is a member of the chromosomally-located
paralogous family 36 which also includes BmpB, BmpC and BmpD (Cabello, Dubytska L,
Bryksin A, Bugrysheva J, & Godfrey HP, 2006; Simpson, Schrumpf ME, & Schwan TG,
1990). Its expression is co-regulated with that of BmpC and BmpB and appears to be subject
to global regulation (Dobrikova, Bugrysheva J, & Cabello FC, 2001; Revel, Talaat AM, &
Norgard MV, 2002; Ramamoorthy, McClain NA, Gautam A, & Scholl-Meeker D, 2005).
BmpA is also involved in borrelial pathogenicity, and participates in development of
borrelial arthritis (Pal, Wang P, Bao F, Yang X, Samanta S, Schoen R, Wormser GP,
Schwartz I, & Fikrig E, 2008).
Attempts at unequivocal demonstration of BmpA surface localization using monoclonal and
polyclonal antibody reagents have produced conflicting results as a result of the incomplete
characterization of their reactivities with all four Bmp proteins (Scriba, Ebrahim JS, Schlott
T, & Eiffert H, 1993; Sullivan, Hechemy KE, Harris HL, Rudofsky UH, Samsonoff WA,
Peterson AJ, Evans BD, & Balaban SL, 1994; Bunikis & Barbour AG, 1999; Pal, Wang P,
Bao F, Yang X, Samanta S, Schoen R, Wormser GP, Schwartz I, & Fikrig E, 2008).
Determination of the cellular localization of BmpA is important because of its involvement
in diagnosis and virulence. For this reason, we have prepared a well-characterized
monospecific anti-rBmpA reagent and have used it to provide definitive evidence for the
display of BmpA on the outer surface of B. burgdorferi.
Materials and Methods
Production of anti-BmpA rabbit antisera
After amplification by PCR from B. burgdorferi B31 genomic DNA, bmpA was cloned in
pQE40 (QIAGEN, Valencia, CA) and bmpB, bmpC, and bmpD were cloned in pET30
(NOVAGEN, EMD Chemicals Inc, NJ). We transformed, expressed and purified rBmpA
from Escherichia coli M15 (pREP4) (Novagen, Madison, WI) and rBmpB, rBmpC and
rBmpD from E. coli BL21 (RIL) (Sambrook & Russell DW, 2001). Cultures were grown at
32°C to 0.5 absorbance units (595 nm), induced with 1 mM isopropyl thiogalactoside
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(Denville Scientific Inc., Metuchen, NJ), and grown for an additional 3 h. rBmpA was
purified from bacterial sonicates using nitriloacetetate-Ni2= affinity chromatography
(Qiagen) and Sephacryl S-300 gel filtration chromatography (GE Healthcare, Piscataway,
NJ). rBmpA purification was monitored by SDS-PAGE and silver staining (Kovarik,
Hlubinova K, Vrbenska A, & Prachar J, 1987; Harlow & Lane D, 1988). Anti-rBmpA
antibodies were raised by intramuscular immunization of 2.5 ± 0.3 kg female New Zealand
white rabbits (Millbrook Breeding Labs, Amherst, MA) with 70 μg of purified rBmpA
emulsified in 50 μl of TiterMax Gold adjuvant (Sigma Chemical Corp., St. Louis, MO),
boosted with 25 μg of rBmpA emulsified in 50 μl of TiterMax Gold 100 days after primary
immunization, and exsanguinated by cardiac puncture under anesthesia 28 days later.
Antibody content of sera was determined by dot immunobinding (Landowski, Godfrey HP,
Bentley-Hibbert SI et al., 2001). Immunoglobulin (Ig) was purified from sera by
precipitation with 50% saturated ammonium sulfate, precipitates were extensively dialyzed
against phosphate-buffered saline (PBS), pH 7.4, and stored in aliquots at −80°C (Harlow &
Lane D, 1988). Protein content was determined by absorbance at 280 nm.
Antibodies
Mouse monoclonal anti-OspA antibodies were a gift from Dr. M. Gomez-Solecki. Rat
polyclonal anti-FlaB was a gift from Drs. M. Caimano and J. D. Radolf to Dr. I. Schwartz.
SDS-PAGE, non-equilibrium pH gradient electrophoresis (2D-NEPHGE) and
immunoblotting
For 2D-NEPHGE (O’Farrell, 1975; Nowalk, Nolder C, Clifton DR, & Carroll JA, 2006;
Nowalk, Gilmore RD, Jr., & Carroll JA, 2006), B. burgdorferi B31 (2.5–5 × 107 cells/ml)
lysates were prepared by sonication of pellets resuspended in 0.05M Tris-HCI (pH 7.4),
0.01M EDTA and 0.3% SDS buffer followed by treatment with 9.5 M (5.045g) urea-2%
(0.2 g) Nonidet P-40-5% (0.5 ml) 2-mercaptoethanol-2% ampholytes (pH 3.0 to 10.0) (Bio-
Rad) (Cox, Akins DR, Bourell KW, Lahdenne P, Norgard MV, & Radolf JD, 1996; Carroll,
Garon CF, & Schwan TG, 1999). For the first dimension of 2D-NEPHGE, a urea-ampholine
isoelectric focusing tube gel was focused for a total of 2,000 Vh. For the second dimension
in 2D-NEPHGE and for SDS-PAGE, 4.5 and 12% polyacrylamide gels were used for
stacking and running gels, respectively. For immunoblotting, proteins were electrolytically
transferred to PVDF membranes (Bio-Rad), developed using enhanced chemiluminescence
technology (ECF Western blotting kit, GE Healthcare), and read using a Storm
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Preparation of monospecific anti-rBmpA
rBmp proteins were induced in E. coli strains using the protocols described above, the
bacteria were lysed by French press, and inclusion bodies obtained by ultracentrifugation.
These inclusion bodies were solubilized in 6M guanidinium HCl-1mM 2-
mercaptoethanol-20 mM HEPES, pH 8.0, and rBmp proteins isolated by immobilized metal
ion affinity chromatography on HisTrap FF columns (GE Healthcare) following the
manufacturer’s instructions. Eluted rBmp proteins were renatured in 100 mM Bis-Tris-
propane, pH 7.0–400 mM magnesium formate, concentrated using Amicon Ultra-4 PL-10
centrifugal filter devices (Millipore, Billerica, MA) and chromatographed on Sephacryl
S-300 (GE Healthcare). Purification of Bmp proteins was monitored by SDS-PAGE and
silver staining. Anti-rBmpA was absorbed with rBmpB immobilized on Affigel15 (Bio-Rad,
Hercules, CA). Monospecificity of adsorbed anti-rBmpA antibodies was confirmed by dot
immunobinding against rBmp proteins and by immunoblotting of 2D-NEPHGE gels of B.
burgdorferi lysates.
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Triton X-114 phase partitioning
To localize BmpA in cell fractions, B. burgdorferi B31 were lysed with 1% (vol/vol) Triton
X-114 (Brandt, Riley BS, Radolf JD, & Norgard MV, 1990; Skare, Shang ES, Foley DM,
Blanco DR, Champion CI, Mirzabekov T, Sokolov Y, Kagan BL, Miller JN, & Lovett MA,
1995). Bacterial cells, 5 × 108 cells/ml, were washed with PBS once, resuspended to 5 × 109
cells/ml in 1% Triton X-114 in PBS, and incubated at 4°C on a rotating platform overnight
(Brusca & Radolf JD, 1994). Isolation of the detergent-insoluble fraction (periplasmic core)
was performed by centrifugation at 15,000 × g, 45 min (Skare, et al., 1995). Phase
partitioning of the detergent-soluble fraction with Triton X-114 was performed by
centrifugation at 15,000 × g for 1 h after an incubation at 37°C for 30 min (Skare, et al.,
1995). Phases were precipitated by 7 volumes of acetone (Cunningham, Walker EM, Miller
JN, & Lovett MA, 1988). The presence of BmpA and FlaB in the different protein fractions
was assessed by immunoblotting with monospecific anti-rBmpA and anti-FlaB, respectively.
Proteinase K digestion
To determine the in situ susceptibility of BmpA to proteolysis, mid-log-phase B. burgdorferi
B31 (100 μl at a concentration 2 × 109 bacteria/ml) were incubated with soluble proteinase
K at final concentrations of 40, 400, or 4,000 μg/ml for 45 min at 25°C in the absence or
presence of 0.05% (vol/vol) Triton X-100 (Cox, Akins DR, Bourell KW, Lahdenne P,
Norgard MV, & Radolf JD, 1996; Bunikis & Barbour AG, 1999; El-Hage, Babb K, Carroll
JA, Lindstrom N, Fischer ER, Miller JC, Gilmore RD, Jr., Mbow ML, & Stevenson B,
2001). The reaction was stopped and proteolysis was inhibited by adding protease inhibitors
(Pefabloc SC (AEBSF), Roche Diagnostics, Mannheim, Germany). Susceptibility of BmpA,
OspA, and FlaB to proteolysis was assessed by immunoblotting.
Dual immunofluorescence labeling
To demonstrate surface exposure of BmpA, 5 × 107 B. burgdorferi B31 were resuspended in
100 μl of BSK-H media and incubated with optimal dilutions of monospecific anti-rBmpA
(1/10 dilution) and mouse anti-OspA (1/50 dilution), with monospecific anti-rBmpA (1/10
dilution) and rat polyclonal anti-FlaB antibodies (1/100), or with similar dilutions of
preimmunization rabbit Ig (Cox, Akins DR, Bourell KW, Lahdenne P, Norgard MV, &
Radolf JD, 1996). Cells were incubated with primary antibodies or preimmunization rabbit
Ig for 1 h at 37°C with gentle mixing, washed three times with 400 μl of PBS supplemented
with 10% fetal calf serum (PBS-FCS). After the final centrifugation cells were resuspended
in 100 μl of PBS-FCS and 15 μl of the washed cells were placed on a glass slide in a circle
marked with wax pencil and allowed to dry at room temperature. Cells were fixed with 4%
formaldehyde-PBS for 20 minutes at 4°C and subsequently washed three times with the
washing buffer described above. Optimal dilutions (1/200 in PBS-FCS) of Alexa Fluor 488
goat anti-rabbit IgG, Alexa Fluor 594 anti-rat IgG and Alexa Fluor 594 anti-mouse IgG
(Molecular Probes, Invitrogen) were used as secondary antibodies. Slides were incubated in
a wet chamber in the dark at room temperature for 1 h, washed three times with PBS-FCS
and once with PBS. They were then fixed a second time with 4% formaldehyde-PBS for 15
minutes at 4°C, mounted in VectaShield media containing DAPI (Vector Laboratories,
Burlingame, CA), covered with a 1 mm coverslip and sealed with nail polish. A similar
protocol was used for B. burgdorferi cells that had been fixed with 50 μl of 60% methanol
for 10 minutes, before being washed and reacted with the primary and secondary antibodies
as described above. Stained cells were visualized with a Zeiss Inverted Axiovert 200
motorized microscope with a 100X (PlanApo 1.4 oil PH3 objective) and Zeiss filter sets 31,
34, and 38 for AlexaFluor 594, 488 and DAPI respectively. The pictures were taken with a
Zeiss Axiocam MRM cool CCD camera and were analyzed using Axiovision 4.3 software.
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Unabsorbed anti-rBmpA Ig had a dot immunobinding titer of 1:10,000 with 10 ng of rBmpA
or rBmpB and reacted minimally with rBmpC or rBmpD. After absorption with rBmpB,
anti-rBmpA Ig had a titer of 1:100 with 1 and 10 ng of rBmpA and did not react with similar
quantities of rBmpB, rBmpC or rBmpD (Fig. 1A2). Absorbed anti-rBmpA at a 1:100
dilution detected a single immunoreactive spot consistent with BmpA at 39 kDa, pI 5.0, in
2D-NEPHGE gels of B. burgdorferi lysates (Fig. 1B). This dilution of this reagent was used
for all subsequent immunoblotting.
Fractionation of intact B. burgdorferi cells with Triton X-114 showed that both
immunoreactive BmpA and FlaB were present in the detergent-insoluble fraction containing
periplasmic core proteins (Fig. 2A, lanes 2), while only BmpA was present in the detergent
phase of the Triton X-114 soluble fraction containing the outer membrane proteins (Fig. 2A,
lanes 4). A small amount of BmpA was also detected in the aqueous phase of the Triton
X-114 soluble fraction (Fig. 2A, lanes 3). Detection of BmpA in the detergent phase of
Triton X-114 fractionation is consistent with its being located in the outer membranes of B.
burgdorferi (Brusca & Radolf JD, 1994;Skare, Shang ES, Foley DM, Blanco DR, Champion
CI, Mirzabekov T, Sokolov Y, Kagan BL, Miller JN, & Lovett MA, 1995). While detection
of immunoreactive BmpA in the Triton X-114-insoluble fraction might imply that some
BmpA is associated with periplasmic cellular proteins and the cytoplasmic membrane, this
fraction also includes intact cells with outer membranes still attached (Crother, Champion
CI, Wu XY, Blanco DR, Miller JN, & Lovett MA, 2003). These data suggest that BmpA,
unlike FlaB, is a lipoprotein, and most probably located in the outer membrane of B.
burgdorferi.
To provide additional data on BmpA localization, intact B. burgdorferi cells were incubated
with increasing concentrations of proteinase K in the absence or presence of Triton X-100.
In the absence of proteinase K, BmpA, OspA, and FlaB were not affected by incubation of
B. burgdorferi with Triton X-100 (Fig. 2B, lanes 1 and 2). In the presence of Triton X-100,
all three proteins were completely digested by proteinase K at final concentrations of 40,
400 (Fig. 2B, lanes 4 and 6) and 4,000 (not shown) μg/ml. In the absence of Triton X-100,
BmpA and OspA were digested by proteinase K at final concentrations of 40 and 400 μg/ml
(Fig. 2B, lanes 3 and 5); FlaB was not (Fig. 2B, lanes 3 and 5). The susceptibility of BmpA
and OspA to proteinase K in intact B. burgdorferi indicates that BmpA, like OspA, is
exposed on the surface of B. burgdorferi. The insensitivity of FlaB to proteinase K in intact
organisms is consistent with its location in the periplasmic space below the surface
membrane (Bunikis & Barbour AG, 1999).
The surface exposure of BmpA in B. burgdorferi B31 was further confirmed by dual-label
indirect immunofluorescence. Intact borrelia cells were double labeled in solution with
optimal dilutions of monospecific anti-rBmpA and anti-OspA antisera or anti-rBmpA and
anti-FlaB antisera. Similar dilutions of preimmunization rabbit Ig were used as controls.
Intact B. burgdorferi showed dual labeling of their surface with anti-rBmpA and anti-OspA
antibodies (Fig. 3) but remained unlabeled by anti-FlaB (Fig. 3) or preimmunization Ig (Fig.
3). After permeabilization of the outer membrane by methanol fixation, B. burgdorferi cells
were labeled by all three antibodies (Fig. 3) but not by preimmunization Ig (Fig. 3). These
results confirm the results of cell fractionation and proteinase K treatment experiments and
indicate that BmpA is exposed on the surface of B. burgdorferi cells (Cox, Akins DR,
Bourell KW, Lahdenne P, Norgard MV, & Radolf JD, 1996).
Previous work with monoclonal anti-BmpA antibodies indicated that BmpA was resistant to
treatment with proteinase K in intact borrelia and suggested its lack of exposure on the
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surface of these cells (Bunikis & Barbour AG, 1999). However, it was not clear from this
earlier study whether the epitopes recognized by this monoclonal antibody were potentially
exposed on the surface of borrelial cells and whether the epitopes it recognized were only
found on BmpA. Experiments with a different monoclonal anti-BmpA antibody and biotin-
labeled intact borrelia suggested that BmpA was probably associated with the cytoplasmic
membrane (Sullivan, Hechemy KE, Harris HL, Rudofsky UH, Samsonoff WA, Peterson AJ,
Evans BD, & Balaban SL, 1994). Here again the epitope recognized was not identified and
the reactivity of this antibody with the other Bmp proteins was not determined. A third
series of experiments concluded that BmpA and FlaB were detected with rat antisera only
when the outer membrane was disrupted but again the specificity of the antisera against
other Bmp proteins was not examined (Cox & Radolf JD, 2001). The monospecificity of our
anti-rBmpA reagent and its lack of reactivity with BmpB, BmpC and BmpD in dot
immunobinding and 2D-NEPHGE is the probable explanation of the differences between
our results and those of previous workers (Sullivan, Hechemy KE, Harris HL, Rudofsky
UH, Samsonoff WA, Peterson AJ, Evans BD, & Balaban SL, 1994; Bunikis & Barbour AG,
1999; Cox & Radolf JD, 2001).
Our results with this well characterized monospecific reagent provide unequivocal evidence
for exposure of BmpA on the surface of B. burgdorferi cells. They are also fully consistent
with earlier suggestive evidence locating BmpA on the surface of borrelial cells (Roessler,
Hauser U, & Wilske B, 1997; Bryksin, et al., 2005) and with the ability of B. burgdorferi
expressing BmpA to elicit proinflammatory cytokines from cultured human synovial cells
and to bind to laminin (Yang, Izadi H, Coleman AS, Wang P, Ma Y, Fikrig E, Anguita J, &
Pal U, 2008; Verma, Brissette CA, Bowman A, & Stevenson B, 2009). They also
complement a recent report demonstrating the virulence activity of BmpA that was based on
a less well-characterized monospecific anti-BmpA reagent (Pal, Wang P, Bao F, Yang X,
Samanta S, Schoen R, Wormser GP, Schwartz I, & Fikrig E, 2008). The availability of
monospecific anti-BmpA antibodies can be critical for future in vitro and in vivo studies of
binding of B. burgdorferi to host molecules and its role in virulence.
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A. Dot immunobinding of rabbit anti-rBmpA before (1) and after (2) absorption with
insolubilized rBmpB to generate a monospecific anti-BmpA reagent. This analysis was
repeated a second time with similar results. B. Immunoblot of B. burgdorferi B31 lysate
proteins separated by 2D-NEPHGE and developed with monospecific anti-rBmpA. A single
reactive spot (arrowhead) consistent with the 39-kDa, pI 5.0, characteristics of BmpA is
detected. This analysis was repeated a second time with similar results. The low molecular
weight spots in the acidic range of the blot are artifacts due to locally high concentrations of
the fluorescent detection agent ECF substrate. See Materials and Methods section for details.
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A. Fractionation of BmpA and FlaB in 2 × 108 B. burgdorferi B31 cells treated with 1%
Triton X-114, separated by SDS PAGE, and developed with anti-rBmpA or anti-FlaB
antibodies. Lanes 1, whole B. burgdorferi B31 treated with Triton X-114; lanes 2, insoluble
material from whole cells treated with Triton X-114; lanes 3, aqueous phase of Triton
X-114-soluble fraction; lanes 4, detergent phase of Triton X-114-soluble fraction. See
Materials and Methods section for details. B. Sensitivity of BmpA, OspA, and FlaB in 2 ×
107 intact B. burgdorferi B31 to digestion by proteinase K in the absence (−) or presence (+)
of 0.05% Triton X-100. Treated cells were lysed and BmpA, OspA and FlaB were analyzed
by SDS-PAGE and immunoblotting using monospecific rabbit anti-rBmpA, monoclonal
mouse anti-OspA, and rat anti-FlaB. See Materials and Methods section for details.
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Dual-labeling indirect immunofluorescence staining of unfixed or methanol-fixed B.
burgdorferi B31 with monospecific rabbit anti-BmpA and monoclonal mouse anti-OspA
antibodies (center panels), or monospecific rabbit anti-rBmpA and rat anti-FlaB antibodies
(right panels). Controls were incubated with preimmunization rabbit Ig and treated as the
experimental slides with Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 594 anti-rat IgG
and Alexa Fluor 594 anti-mouse IgG. Only controls reacted with anti rabbit AlexaFluor 488
and DAPI are displayed ((left panels). The DAPI fluorescent stain was used to monitor the
presence of borreliae on a slide. See Materials and Methods section for details.
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